$470.00
| Cat No. | RCHM-02072 |
| Package Unit | 20 tests/kit |
| Kit Component | 20 Test devices 20 Assay buffer 20 Extraction vials and caps 20 Specimen collection swabs 1 Positive and 1 negative control swabs 1 Instructions for use |
A valid CLIA waiver is required to purchase this product. Click here for more information on CLIA wavers.
Description
Due to the highly contagious nature and global health crisis, SARS-CoV-2 has been designated as a pandemic by the World Health Organization (WHO) and continues to have devastating impacts on healthcare systems and the world economy including the U.S. To effectively end the SARS-CoV-2 pandemic, systematic screening, and detection of both clinical and asymptomatic COVID-19 cases is critical.
As an intended point-of-care (POC) designated test with a 10 minute processing time, CareStartTM COVID-19 Antigen Test allows effective screening of COVID-19 infection on a large scale.
Features
- Lateral flow assay
- Rapid results in 10 minutes
- Minimally invasive specimen collection (nasopharyngeal)
- Intended at POC setting (i.e., in patient care settings) by medical professionals
Clinical Features
- Detect SARS-CoV-2 nucleocapsid protein antigen
- Identify acute infection with high sensitivity and 100% specificity
